Demand for GLP-1 receptor agonists is expected to grow at an 11.7% CAGR between 2026 and 2036
Pharmacol Ther (2022) 239:108277
Introduction With a worldwide prevalence of approximately 4%, irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders (FGIDs) (Sperber et al., 2021)
Other potential dangers include inconsistent ingredient concentrations and formulations that haven't been tested in clinical trials
The most common reasons why many users take L-Carnitine are to help them lose fat , enhance power and endurance, reduce fatigue, and quicken recovery
Obesity and metabolic conditions are among the most urgent health challenges worldwide , affecting over one-third of adults and contributing to diabetes, heart disease, and fatty liver disease